Lyra Therapeutics, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Lyra Therapeutics, Inc. quarterly/annual Payments to Acquire Property, Plant, and Equipment history and growth rate from Q1 2019 to Q1 2024.
  • Lyra Therapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending March 31, 2024 was $2.15M, a 4676% increase year-over-year.
  • Lyra Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $1.05M, a 538% increase from 2022.
  • Lyra Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $164K, a 95.2% decline from 2021.
  • Lyra Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2021 was $3.39M, a 90.7% increase from 2020.
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $2.15M +$2.1M +4676% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-30
Q1 2023 $45K -$48K -51.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-30
Q1 2022 $93K -$1.07M -92% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q1 2021 $1.16M +$1.15M +14400% Jan 1, 2021 Mar 31, 2021 10-Q/A 2022-11-02
Q1 2020 $8K -$44K -84.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q1 2019 $52K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.